SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): January 28, 1999
HUMAN PHEROMONE SCIENCES, INC.
- --------------------------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
CALIFORNIA 0-23544 94-3107202
- --------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
4034 CLIPPER COURT, FREMONT, CALIFORNIA 94538
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (510) 226-6874
----------------------------
- --------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
INFORMATION TO BE INCLUDED IN THE REPORT
ITEM 5. OTHER EVENTS
<TABLE>
The following unaudited balance sheet information as of
December 31, 1998 is being provided by the Registrant at the request of the
Nasdaq Stock Market.
HUMAN PHEROMONE SCIENCES, INC.
Unaudited Balance Sheet Information
December 31, 1998
<CAPTION>
December 31,
1998
------------
<S> <C>
Assets
Current assets:
Cash and cash equivalents $ 76,696
Accounts receivable, net of allowances of $677,735 2,051,574
Inventory 2,894,541
Other current assets 138,635
------------
Total current assets 5,161,446
Property and equipment, net 58,596
------------
$ 5,220,042
============
Liabilities and Shareholders' equity
Current liabilities:
Accounts payable $ 691,674
Loan payable, bank 773,534
Other accrued expenses 1,345,204
------------
Total current liabilities 2,810,412
Commitments --
Shareholders' equity:
Convertible preferred stock, issuable in series,
no par value, 10,000,000 shares authorized,
1,439,333 issued and outstanding 2,745,535
Common stock, no par value, 40,000,000 shares authorized,
10,289,488 shares issued and outstanding 17,667,024
Accumulated deficit (18,002,929)
------------
Total shareholders' equity 2,409,630
------------
$ 5,220,042
============
</TABLE>
-2-
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
HUMAN PHEROMONE SCIENCES, INC.
Date: January 28, 1999 By: /s/ William P. Horgan
--------------------------------------------
William P. Horgan, Chief Executive Officer
-3-
